Rite Aid (RADCQ)
(Delayed Data from OTC)
$0.12 USD
0.00 (0.00%)
Updated Jun 7, 2024 03:57 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
RADCQ 0.12 0.00(0.00%)
Will RADCQ be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for RADCQ based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for RADCQ
Zacks Industry Outlook Highlights CVS Health, Herbalife, Rite Aid and Amazon
3 Retail Pharmacy & Drugstore Stocks to Watch Amid Industry Headwinds
RADCQ: What are Zacks experts saying now?
Zacks Private Portfolio Services
Walgreens Boots Alliance (WBA) Tops Q1 Earnings and Revenue Estimates
Costco (COST) Q1 Earnings and Revenues Beat Estimates
Other News for RADCQ
As pharmacies shutter, some Western states, Black and Latino communities are left behind
Rite Aid said to be nearing post-bankruptcy financing deal
Realty Income Q1: Not A Bargain, But Still One Of The Best REITs For Income Reliability (Rating Downgrade)
Shoplifting crackdown: Retail theft ring targeting Macy's, other retailers busted
CVS Health: A Terrible Earnings Report, But An Undervalued Stock